{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:15:22Z","timestamp":1795144522352,"version":"4.10.3"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001537","name":"The University of Auckland","doi-asserted-by":"publisher","award":["3717415"],"award-info":[{"award-number":["3717415"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018883","name":"Maurice Wilkins Centre for Molecular Biodiscovery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1120018"],"award-info":[{"award-number":["1120018"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.omtn.2025.102472","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T02:32:38Z","timestamp":1738377158000},"page":"102472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-0122","authenticated-orcid":false,"given":"John M.T.","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"du Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Verdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Clemance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evert","family":"Loef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Malhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Buttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.H.F.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yale S.","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Garlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Rod","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Purvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughan","family":"Feisst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-4618","authenticated-orcid":false,"given":"Hilary","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102472_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","article-title":"Epidermolysis bullosa","volume":"6","author":"Bardhan","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.omtn.2025.102472_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","article-title":"A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa","volume":"16","author":"Tang","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2025.102472_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042243","article-title":"Emerging Gene Therapeutics for Epidermolysis Bullosa under Development","volume":"25","author":"Bischof","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102472_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102472_bib5","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.drudis.2022.06.006","article-title":"Small-molecule enhancers of CRISPR-induced homology-directed repair in gene therapy: A medicinal chemist\u2019s perspective","volume":"27","author":"Lee","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtn.2025.102472_bib6","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ymthe.2021.02.019","article-title":"Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing","volume":"29","author":"Bonafont","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102472_bib7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jid.2023.10.035","article-title":"Highly efficient ex-vivo correction of COL7A1 through RNP-based CRISPR\/Cas9 and Homology-Directed Repair to treat recessive dystrophic epidermolysis bullosa","volume":"144","author":"Berthault","year":"2024","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2025.102472_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.omtn.2019.09.011","article-title":"Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination","volume":"18","author":"Kocher","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102472_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtn.2021.05.015","article-title":"A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa","volume":"25","author":"Kocher","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102472_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.omtn.2018.06.008","article-title":"Ex\u00a0Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR\/Cas9 and Homology-Directed Repair","volume":"12","author":"Izmiryan","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102472_bib11","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1073\/pnas.1907081116","article-title":"CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells","volume":"116","author":"Jack\u00f3w","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102472_bib12","article-title":"AAV-based CRISPR-Cas9 genome editing: Challenges and engineering opportunities","volume":"29","author":"Kabadi","year":"2024","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.omtn.2025.102472_bib13","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ymthe.2024.03.006","article-title":"On- and off-target effects of paired CRISPR-Cas nickase in primary human cells","volume":"32","author":"Klermund","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102472_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100343","article-title":"Efficient dual Cas9 nickase correction of a prevalent pathogenic LAMB3 variant for junctional epidermolysis bullosa","volume":"5","author":"du Rand","year":"2025","journal-title":"JID Innov."},{"key":"10.1016\/j.omtn.2025.102472_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jdermsci.2021.09.006","article-title":"Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa","volume":"104","author":"Woodley","year":"2021","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.omtn.2025.102472_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10640","article-title":"Highly efficient CRISPR\/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa","volume":"9","author":"du Rand","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102472_bib17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.jid.5700219","article-title":"Expanding the COL7A1 mutation database: Novel and recurrent mutations and unusual genotype - Phenotype constellations in 41 patients with dystrophic epidermolysis bullosa","volume":"126","author":"Kern","year":"2006","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2025.102472_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.91288.3","article-title":"Near-perfect precise on-target editing of human hematopoietic stem and progenitor cells","volume":"12","author":"Cloarec-Ung","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.omtn.2025.102472_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102472_bib20","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1093\/nar\/gkz669","article-title":"Simultaneous precise editing of multiple genes in human cells","volume":"47","author":"Riesenberg","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102472_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.semcdb.2012.09.011","article-title":"Capturing epidermal stemness for regenerative medicine","volume":"23","author":"Barrandon","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.omtn.2025.102472_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","article-title":"CRISPR-based genome editing through the lens of DNA repair","volume":"82","author":"Nambiar","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102472_bib23","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/s41467-021-22779-9","article-title":"Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells","volume":"12","author":"Enzo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102472_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI115557","article-title":"Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes","volume":"89","author":"Ryyn\u00e4nen","year":"1992","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102472_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41421-019-0088-8","article-title":"Optimizing genome editing strategy by primer-extension-mediated sequencing","volume":"5","author":"Yin","year":"2019","journal-title":"Cell Discov."},{"key":"10.1016\/j.omtn.2025.102472_bib26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-019-09006-2","article-title":"CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations","volume":"10","author":"Cullot","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102472_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","article-title":"In\u00a0vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","volume":"28","author":"Gurevich","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102472_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40291-022-00613-2","article-title":"Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds","volume":"26","author":"du Rand","year":"2022","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.omtn.2025.102472_bib29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/14712598.2022.2049229","article-title":"Current developments in gene therapy for epidermolysis bullosa","volume":"22","author":"Kocher","year":"2022","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2025.102472_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.omtm.2022.09.005","article-title":"Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in\u00a0vivo CRISPR-Cas9 delivery using adenoviral vectors","volume":"27","author":"Garc\u00eda","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102472_bib31","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR\/Cas9-Mediated Gene Editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102472_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101134","article-title":"CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102472_bib33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/crispr.2021.0132","article-title":"Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas9","volume":"5","author":"Bchetnia","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtn.2025.102472_bib34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ymthe.2023.11.027","article-title":"Allele-specific CRISPR-Cas9 editing of dominant epidermolysis bullosa simplex in human epidermal stem cells","volume":"32","author":"Cattaneo","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102472_bib35","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102472_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.21651","article-title":"The COL7A1 mutation database","volume":"33","author":"Wertheim-Tysarowska","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2025.102472_bib37","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/humu.21551","article-title":"The international dystrophic epidermolysis bullosa patient registry: An online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations","volume":"32","author":"Van den Akker","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2025.102472_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ajd.13762","article-title":"Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand","volume":"63","author":"Gear","year":"2022","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.omtn.2025.102472_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jdermsci.2007.02.006","article-title":"Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants","volume":"46","author":"Dang","year":"2007","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.omtn.2025.102472_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/ced.13407","article-title":"Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico","volume":"43","author":"Saeidian","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.omtn.2025.102472_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jdermsci.2020.04.004","article-title":"Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR\/Cas9 and piggyBac transposon system","volume":"98","author":"Itoh","year":"2020","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.omtn.2025.102472_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00439-023-02561-1","article-title":"Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells","volume":"142","author":"Hunt","year":"2023","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2025.102472_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.976604","article-title":"COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa","volume":"9","author":"Petkovi\u0107","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2025.102472_bib44","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2025.102472_bib45","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1158\/0008-5472.CAN-20-1672","article-title":"Exploiting the Microhomology-Mediated End-Joining Pathway in Cancer Therapy","volume":"80","author":"Patterson-Fortin","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2025.102472_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13059-021-02462-4","article-title":"Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion","volume":"22","author":"Wen","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2025.102472_bib47","first-page":"1","article-title":"Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations","volume":"2024","author":"Cullot","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102472_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: A highly sensitive in\u00a0vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2025.102472_bib49","doi-asserted-by":"crossref","first-page":"19482","DOI":"10.1038\/s41598-021-98965-y","article-title":"Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair","volume":"11","author":"Schubert","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102472_bib50","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102472_bib51","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.molcel.2021.03.032","article-title":"Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance","volume":"81","author":"Schep","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102472_bib52","doi-asserted-by":"crossref","first-page":"26372","DOI":"10.1074\/jbc.M203247200","article-title":"Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen","volume":"277","author":"Rattenholl","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102472_bib53","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.molcel.2016.04.006","article-title":"Epigenome Maintenance in Response to DNA Damage","volume":"62","author":"Dabin","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102472_bib54","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1093\/nar\/gkz459","article-title":"Microhomologies are prevalent at Cas9-induced larger deletions","volume":"47","author":"Owens","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102472_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12915-024-01896-z","article-title":"Modulation of the microhomology-mediated end joining pathway suppresses large deletions and enhances homology-directed repair following CRISPR-Cas9-induced DNA breaks","volume":"22","author":"Yuan","year":"2024","journal-title":"BMC Biol."},{"key":"10.1016\/j.omtn.2025.102472_bib56","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1038\/s41467-023-40344-4","article-title":"Simultaneous inhibition of DNA-PK and Pol\u03f4 improves integration efficiency and precision of genome editing","volume":"14","author":"Wimberger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102472_bib57","first-page":"1","article-title":"A bioinformatic analysis of gene editing off-target loci altered by common polymorphisms, using \u2018PopOff\u2019","author":"Samson","year":"2024","journal-title":"J.\u00a0Roy. Soc. N. Z."},{"key":"10.1016\/j.omtn.2025.102472_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcyt.2022.09.003","article-title":"Rapid culture of human keratinocytes in an autologous, feeder-free system with a novel growth medium","volume":"25","author":"Feisst","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtn.2025.102472_bib59","article-title":"Human keratinocytes grown at a gas-permeable interface in vitro stratify correctly to generate engineered human epidermis","author":"Feisst","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtn.2025.102472_bib60","article-title":"Three-Dimensional Tissue Models of Normal and Diseased Skin","volume":"Chapter 19","author":"Carlson","year":"2008","journal-title":"Curr. Protoc. Cell Biol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:23:28Z","timestamp":1762601008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2162253125000265"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102472","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102472"}}